The information provided has been reviewed by licensed healthcare professionals but shouldn't replace a consultation with your physician
Always consult a licensed clinician before starting, stopping, or changing any medication
Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors, which is why clinical trials have shown it producing greater average weight loss than semaglutide alone
Thirdly, GLP-1 agonists slow gastric emptying, leading to a delayed absorption of nutrients and a prolonged feeling of fullness, which can contribute to reduced food intake and weight loss
Anybody would be lucky to have someone like Toni in their corner
Reconstitution Support Because peptides must be reconstituted before any measurement, the tool also doubles as a Retatrutide peptide reconstitution calculator